ImmunologybioRxivPreprint
A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease
Marie Binvignat, Federica Martina, Fabien Pitoiset…·Encarnita Mariotti‐Ferrandiz
The paper identifies a shared Treg dysfunction signature across rheumatic diseases, suggesting a therapeutic window of opportunity for Treg-targeted treatments.
DOI 10.64898/2026.09.21.753213